← Leaderboards
Joshua A Boyce
Brigham And Women'S Hospital
$54,050,346
Attributed
$56,329,243
Total exposure
23
Grants
20
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.3M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$100,274,260 · 26
By mechanism
U19$35,250,182 · 8
R01$25,855,136 · 7
P01$14,324,283 · 3
U01$12,234,360 · 2
T32$5,882,452 · 1
R37$5,206,338 · 1
Top collaborators
- Mark A Birrell4 shared
- Ramaswamy Krishnan4 shared
- Raymond B. Penn4 shared
- Elliot Israel3 shared
- Nora Amanda Barrett2 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Nora Amanda Barrett$12,519,597
- Barbara Balestrieri$2,989,471
- Carrie L Pistenmaa$982,810
- K. Frank Austen$8,663,173
- Christina M Parker$567,331
Others in their field
Top investigators on “Asthma”
- James E. Gern · University Of Wisconsin-Madison$159,588,264
- William W. Busse · University Of Wisconsin Madison$104,093,792
- Scott T Weiss · University Of California, San Diego$98,211,117
- David T Mauger · Pennsylvania State Univ Hershey Med Ctr$79,309,576
- Fernando D Martinez · University Of Arizona$66,357,737
- Wanda Phipatanakul · Boston Children'S Hospital$50,505,446
Research focus
AsthmaTissuesReceptorInflammationCellsMast CellFunctional DisorderPathway InteractionsCysteinyl-LeukotrieneCytokineSignal TransductionAspirin-Exacerbated Respiratory DiseaseResponseMediatingGenerationsDinoprostoneProductionRespiratoryMolecularLungAspirinPhenotypeIn VivoNose
Grant awards (148)
Pathophysiologic and Therapeutic Mechanisms of Aspirin Exacerbated Respiratory Disease$1,535,611
U19 · FY2025 · AI · contact PI
Prostaglandin E2-Dependent Control of a Mast Cell IL-33/ST2 Pathway in Asthma$859,874
R01 · FY2025 · AI · contact PI
Control of Pulmonary Inflammation by Leukotriene E4$700,679
R01 · FY2025 · AI · contact PI
Immunologic Basis of Resistance and Hypersensitivity$651,590
T32 · FY2025 · AI · contact PI
Eicosanoid Networks in Aspirin Hypersensitivity$636,768
R01 · FY2025 · AI · contact PI
Project 1. Regulation of Mast Cell Homeostasis in Type 2 Immunopathology$436,853
U19 · FY2025 · AI · contact PI
Core A: Administrative Core$30,226
U19 · FY2025 · AI · contact PI
Pathophysiologic and Therapeutic Mechanisms of Aspirin Exacerbated Respiratory Disease$1,535,611
U19 · FY2024 · AI · contact PI
Prostaglandin E2-Dependent Control of a Mast Cell IL-33/ST2 Pathway in Asthma$859,874
R01 · FY2024 · AI · contact PI
Control of Pulmonary Inflammation by Leukotriene E4$700,679
R01 · FY2024 · AI · contact PI
Eicosanoid Networks in Aspirin Hypersensitivity$656,461
R01 · FY2024 · AI · contact PI
Immunologic Basis of Resistance and Hypersensitivity$617,929
T32 · FY2024 · AI · contact PI
Project 1. Regulation of Mast Cell Homeostasis in Type 2 Immunopathology$432,834
U19 · FY2024 · AI · contact PI
Pathophysiologic and Therapeutic Mechanisms of Aspirin Exacerbated Respiratory Disease$173,820
U19 · FY2024 · AI · contact PI
Core A: Administrative Core$29,945
U19 · FY2024 · AI · contact PI
Pathophysiologic and Therapeutic Mechanisms of Aspirin Exacerbated Respiratory Disease$1,535,611
U19 · FY2023 · AI · contact PI
Prostaglandin E2-Dependent Control of a Mast Cell IL-33/ST2 Pathway in Asthma$859,235
R01 · FY2023 · AI · contact PI
Control of Pulmonary Inflammation by Leukotriene E4$700,679
R01 · FY2023 · AI · contact PI
Eicosanoid Networks in Aspirin Hypersensitivity$656,461
R01 · FY2023 · AI · contact PI
Project 1. Regulation of Mast Cell Homeostasis in Type 2 Immunopathology$534,112
U19 · FY2023 · AI · contact PI
Immunologic Basis of Resistance and Hypersensitivity$358,696
T32 · FY2023 · AI · contact PI
Core A: Administrative Core$47,052
U19 · FY2023 · AI · contact PI
Pathophysiologic and Therapeutic Mechanisms of Aspirin Exacerbated Respiratory Disease$1,535,611
U19 · FY2022 · AI · contact PI
Control of Pulmonary Inflammation by Leukotriene E4$700,679
R01 · FY2022 · AI · contact PI
Eicosanoid Networks in Aspirin Hypersensitivity$549,828
R01 · FY2022 · AI · contact PI
CysLT and P2Y Receptors in Lung Inflammation$535,507
R37 · FY2022 · AI · contact PI
Immunologic Basis of Resistance and Hypersensitivity$508,707
T32 · FY2022 · AI · contact PI
Project 1. Regulation of Mast Cell Homeostasis in Type 2 Immunopathology$419,990
U19 · FY2022 · AI · contact PI
Core A: Administrative Core$63,330
U19 · FY2022 · AI · contact PI
Pathophysiologic and Therapeutic Mechanisms of Aspirin Exacerbated Respiratory Disease$1,535,096
U19 · FY2021 · AI · contact PI
Control of Pulmonary Inflammation by Leukotriene E4$700,679
R01 · FY2021 · AI · contact PI
Eicosanoid Networks in Aspirin Hypersensitivity$549,828
R01 · FY2021 · AI · contact PI
CysLT and P2Y Receptors in Lung Inflammation$535,507
R37 · FY2021 · AI · contact PI
Immunologic Basis of Resistance and Hypersensitivity$495,511
T32 · FY2021 · AI · contact PI
Project 1. Regulation of Mast Cell Homeostasis in Type 2 Immunopathology$381,034
U19 · FY2021 · AI · contact PI
Core A: Administrative Core$61,370
U19 · FY2021 · AI · contact PI
Pathophysiologic and Therapeutic Mechanisms in Aspirin Exacerbated Respiratory Disease$1,543,357
U19 · FY2020 · AI · contact PI
Project 1: Eicosanoid Regulation of Type 2 Immunity in AERD$803,454
U19 · FY2020 · AI · contact PI
Eicosanoid Networks in Aspirin Hypersensitivity$549,828
R01 · FY2020 · AI · contact PI
Optimizing EP receptor subtype targeting for asthma therapy$537,546
R01 · FY2020 · HL
CysLT and P2Y Receptors in Lung Inflammation$535,507
R37 · FY2020 · AI · contact PI
Regulation of Pulmonary Inflammation by Leukotriene E4$515,835
R01 · FY2020 · AI · contact PI
Immunologic Basis of Resistance and Hypersensitivity$455,004
T32 · FY2020 · AI · contact PI
Influence of NSAIDs and AERD on the expression and function of ACE2 - implications for SARS-CoV2 severity$114,202
U19 · FY2020 · AI · contact PI
Core A: Administration$54,766
U19 · FY2020 · AI · contact PI
Pathophysiologic and Therapeutic Mechanisms in Aspirin Exacerbated Respiratory Disease$1,543,357
U19 · FY2019 · AI · contact PI
Eicosanoid Networks in Aspirin Hypersensitivity$549,828
R01 · FY2019 · AI · contact PI
Optimizing EP receptor subtype targeting for asthma therapy$537,546
R01 · FY2019 · HL
CysLT and P2Y Receptors in Lung Inflammation$535,507
R37 · FY2019 · AI · contact PI
Regulation of Pulmonary Inflammation by Leukotriene E4$515,835
R01 · FY2019 · AI · contact PI
Immunologic Basis of Resistance and Hypersensitivity$480,607
T32 · FY2019 · AI · contact PI
Project 1: Eicosanoid Regulation of Type 2 Immunity in AERD$276,969
U19 · FY2019 · AI · contact PI
Core A: Administration$75,878
U19 · FY2019 · AI · contact PI
Pathophysiologic and Therapeutic Mechanisms in Aspirin Exacerbated Respiratory Disease$1,543,357
U19 · FY2018 · AI · contact PI
Eicosanoid Networks in Aspirin Hypersensitivity$549,828
R01 · FY2018 · AI · contact PI
Optimizing EP receptor subtype targeting for asthma therapy$537,546
R01 · FY2018 · HL
CysLT and P2Y Receptors in Lung Inflammation$535,507
R37 · FY2018 · AI · contact PI
Regulation of Pulmonary Inflammation by Leukotriene E4$515,835
R01 · FY2018 · AI · contact PI
Immunologic Basis of Resistance and Hypersensitivity$491,582
T32 · FY2018 · AI · contact PI
Project 1: Eicosanoid Regulation of Type 2 Immunity in AERD$276,967
U19 · FY2018 · AI · contact PI
Core A: Administration$75,880
U19 · FY2018 · AI · contact PI
Pathophysiologic and Therapeutic Mechanisms in Aspirin Exacerbated Respiratory Disease$1,978,951
U19 · FY2017 · AI · contact PI
CysLT and P2Y Receptors in Lung Inflammation$626,478
R37 · FY2017 · AI · contact PI
Optimizing EP receptor subtype targeting for asthma therapy$579,546
R01 · FY2017 · HL
Regulation of Pulmonary Inflammation by Leukotriene E4$515,835
R01 · FY2017 · AI · contact PI
Project 1: Eicosanoid Regulation of Type 2 Immunity in AERD$469,075
U19 · FY2017 · AI · contact PI
Immunologic Basis of Resistance and Hypersensitivity$468,641
T32 · FY2017 · AI · contact PI
Core A: Administration$75,878
U19 · FY2017 · AI · contact PI
Pathophysiologic and Therapeutic Mechanisms in Aspirin Exacerbated Respiratory Disease$1,543,357
U19 · FY2016 · AI · contact PI
Regulation of Pulmonary Inflammation by Leukotriene E4$515,835
R01 · FY2016 · AI · contact PI
CysLT and P2Y Receptors in Lung Inflammation$484,423
R37 · FY2016 · AI · contact PI
Immunologic Basis of Resistance and Hypersensitivity$455,901
T32 · FY2016 · AI · contact PI
Eicosanoid Networks in Aspirin Exacerbated Respiratory Disease$384,274
R01 · FY2016 · HL · contact PI
Project 1: Eicosanoid Regulation of Type 2 Immunity in AERD$266,811
U19 · FY2016 · AI · contact PI
Characterization of a Novel Growth and Survival Factor for Human Mast Cells$266,250
R21 · FY2016 · AI · contact PI
Core A: Administration$73,095
U19 · FY2016 · AI · contact PI
Pathophysiologic and therapeutic mechanisms of aspirin exacerbated respiratory disease$1,986,118
U19 · FY2015 · AI · contact PI
Mechanisms and Consequences of Defective E Prostanoid Receptor Signaling in AERD$883,728
U19 · FY2015 · AI · contact PI
CysLT and P2Y Receptors in Lung Inflammation$483,494
R37 · FY2015 · AI · contact PI
Regulation of Pulmonary Inflammation by Leukotriene E4$480,798
R01 · FY2015 · AI · contact PI
Immunologic Basis of Resistance and Hypersensitivity$455,447
T32 · FY2015 · AI · contact PI
Eicosanoid Networks in Aspirin Exacerbated Respiratory Disease$378,510
R01 · FY2015 · HL · contact PI
Characterization of a Novel Growth and Survival Factor for Human Mast Cells$221,355
R21 · FY2015 · AI · contact PI
Administrative Core$74,760
U19 · FY2015 · AI · contact PI
Pathophysiologic and therapeutic mechanisms of aspirin exacerbated respiratory d*$1,935,073
U19 · FY2014 · AI · contact PI
Mechanisms and Consequences of Defective E Prostanoid Receptor Signaling in AERD$766,313
U19 · FY2014 · AI · contact PI
CysLT and P2Y Receptors in Lung Inflammation$482,254
R37 · FY2014 · AI · contact PI
Regulation of Pulmonary Inflammation by Leukotriene E4$480,798
R01 · FY2014 · AI · contact PI
Immunologic Basis of Resistance and Hypersensitivity$442,837
T32 · FY2014 · AI · contact PI
Eicosanoid Networks in Aspirin Exacerbated Respiratory Disease$375,951
R01 · FY2014 · HL · contact PI
Pathophysiologic and therapeutic mechanisms of aspirin exacerbated respiratory d*$148,056
U19 · FY2014 · AI · contact PI
Mechanisms and Consequences of Defective E Prostanoid Receptor Signaling in AERD$148,056
U19 · FY2014 · AI · contact PI
Administrative Core$83,633
U19 · FY2014 · AI · contact PI
Pathophysiologic and therapeutic mechanisms of aspirin exacerbated respiratory d*$2,279,967
U19 · FY2013 · AI · contact PI
Mechanisms and Consequences of Defective E Prostanoid Receptor Signaling in AERD$748,285
U19 · FY2013 · AI · contact PI
CysLT and P2Y Receptors in Lung Inflammation$452,154
R37 · FY2013 · AI · contact PI
Regulation of Pulmonary Inflammation by Leukotriene E4$451,950
R01 · FY2013 · AI · contact PI
Eicosanoid Networks in Aspirin Exacerbated Respiratory Disease$369,821
R01 · FY2013 · HL · contact PI
Administrative Core$81,664
U19 · FY2013 · AI · contact PI
Kit Inhibition in Asthma (KIA)$2,548,859
U01 · FY2012 · HL
Ancillary Study$2,281,109
U01 · FY2012 · HL · contact PI
Pathophysiologic and therapeutic mechanisms of aspirin exacerbated respiratory d*$1,787,094
U19 · FY2012 · AI · contact PI
Mechanisms and Consequences of Defective E Prostanoid Receptor Signaling in AERD$708,240
U19 · FY2012 · AI · contact PI
Regulation of Pulmonary Inflammation by Leukotriene E4$480,798
R01 · FY2012 · AI · contact PI
CysLT and P2Y Receptors in Lung Inflammation$414,092
R01 · FY2012 · AI · contact PI
Administrative Core$77,296
U19 · FY2012 · AI · contact PI
Kit Inhibition in Asthma (KIA)$2,294,684
U01 · FY2011 · HL
Ancillary Study$2,294,684
U01 · FY2011 · HL · contact PI
Pathophysiologic and therapeutic mechanisms of aspirin exacerbated respiratory d*$1,782,897
U19 · FY2011 · AI · contact PI
Mechanisms and Consequences of Defective E Prostanoid Receptor Signaling in AERD$521,576
U19 · FY2011 · AI · contact PI
CysLT and P2Y Receptors in Lung Inflammation$414,092
R01 · FY2011 · AI · contact PI
Administrative Core$233,966
U19 · FY2011 · AI · contact PI
Kit Inhibition in Asthma (KIA)$1,407,512
U01 · FY2010 · HL
Ancillary Study$1,407,512
U01 · FY2010 · HL · contact PI
CysLT and P2Y Receptors in Lung Inflammation$418,275
R01 · FY2010 · AI · contact PI
Regulation of Pulmonary Prostaglandins by Leukotriene E4$397,733
R01 · FY2010 · AI · contact PI
Lipidomic and Transcriptome Signatures in Aspirin-Exacerbated Respiratory Disease$220,275
R21 · FY2010 · AI · contact PI
Chemical Mediators of Acute Pulmonary Disorders$2,448,146
P01 · FY2009 · HL · contact PI
Role of PGE2 in Human Mast Cell Biology$516,823
P01 · FY2009 · HL · contact PI
CysLT and P2Y Receptors in Lung Inflammation$422,500
R01 · FY2009 · AI · contact PI
Regulation of Pulmonary Prostaglandins by Leukotriene E4$396,681
R01 · FY2009 · AI · contact PI
CysLT and P2Y Receptors in Lung Inflammation$289,684
R01 · FY2009 · AI · contact PI
Lipidomic and Transcriptome Signatures in Aspirin-Exacerbated Respiratory Disease$266,500
R21 · FY2009 · AI · contact PI
CysLT and P2Y Receptors in Lung Inflammation$22,303
R01 · FY2009 · AI · contact PI
Chemical Mediators of Acute Pulmonary Disorders$2,333,695
P01 · FY2008 · HL · contact PI
Role of PGE2 in Human Mast Cell Biology$494,274
P01 · FY2008 · HL · contact PI
CysLT and P2Y Receptors in Lung Inflammation$211,250
R01 · FY2008 · AI · contact PI
Chemical Mediators of Acute Pulmonary Disorders$2,316,444
P01 · FY2007 · HL · contact PI
Role of PGE2 in Human Mast Cell Biology$509,444
P01 · FY2007 · HL · contact PI
CysLt and P2Y Receptors and Lung Inflammation$418,609
R56 · FY2007 · AI · contact PI
Chemical Mediators of Acute Pulmonary Disorders$2,320,759
P01 · FY2006 · HL · contact PI
Role of PGE2 in Human Mast Cell Biology$517,979
P01 · FY2006 · HL · contact PI
CystLT and P2Y Receptors and Lung Inflammation$408,079
R01 · FY2006 · AI · contact PI
The Role of Mast Cells in Lung Inflammation$367,500
R01 · FY2006 · AI · contact PI
Chemical Mediators of Acute Pulmonary Disorders$2,237,772
P01 · FY2005 · HL
Role of PGE2 in Human Mast Cell Biology$426,115
P01 · FY2005 · HL
CystLT and P2Y Receptors and Lung Inflammation$417,900
R01 · FY2005 · AI
The Role of Mast Cells in Lung Inflammation$376,719
R01 · FY2005 · AI
CystLT and P2Y Receptors and Lung Inflammation$417,900
R01 · FY2004 · AI
The Role of Mast Cells in Lung Inflammation$377,084
R01 · FY2004 · AI
CystLT and P2Y Receptors and Lung Inflammation$417,900
R01 · FY2003 · AI
The Role of Mast Cells in Lung Inflammation$377,421
R01 · FY2003 · AI
The Role of Mast Cells in Lung Inflammation$376,860
R01 · FY2002 · AI
CystLT and P2Y Receptors and Lung Inflammation$375,696
R01 · FY2002 · AI
Phenotypic Regulation of Human Mast Cells$0
P01 · FY2002 · AI
Phenotypic Regulation of Human Mast Cells$0
P01 · FY2001 · AI
Phenotypic Regulation of Human Mast Cells$202,832
P01 · FY2000 · AI
FUNCTION OF IMMATURE HYPODENSE HUMAN EOSINOPHILS$128,520
K11 · FY2000 · AI